中文：

安必平是一款由广州安必平医药科技有限公司研发的肿瘤基因检测试剂盒，该产品于2019年1月25日正式上市。安必平的上市为中国肿瘤患者提供了更为精准的基因检测服务，有助于提高肿瘤患者的生存率和生活质量。

安必平的研发团队经过多年的努力，成功开发出了具有自主知识产权的肿瘤基因检测技术，该技术采用液相基因捕获和深度测序技术，可以检测100多个肿瘤相关基因的变异情况，从而为肿瘤患者提供个性化的诊疗方案。

安必平的上市得到了国家药品监督管理局的批准，并且通过了多项质量认证和临床试验验证。该产品的上市不仅为肿瘤患者提供了更为精准的基因检测服务，同时也为中国的肿瘤基因检测行业树立了标杆和榜样。

英文：

AmpliPlex is a tumor gene detection kit developed by Guangzhou AmpliPlex Biotechnology Co., Ltd. The product was officially launched on January 25, 2019. AmpliPlex's launch provides more accurate gene detection services for Chinese cancer patients, helping to improve survival rates and quality of life.

The AmpliPlex research team has developed a tumor gene detection technology with independent intellectual property rights through years of effort. This technology adopts liquid-phase gene capture and deep sequencing technology, which can detect mutations in more than 100 tumor-related genes, providing personalized treatment plans for cancer patients.

AmpliPlex's launch has been approved by the National Medical Products Administration, and has passed multiple quality certifications and clinical trial verifications. The launch of this product not only provides more accurate gene detection services for cancer patients, but also sets an example for China's tumor gene detection industry.